Vertex Planning Partners LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vertex Planning Partners LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 851 shares of the medical equipment provider’s stock after buying an additional 30 shares during the quarter. Vertex Planning Partners LLC’s holdings in Intuitive Surgical were worth $444,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management raised its position in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the last quarter. Exome Asset Management LLC lifted its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $507.90 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s 50-day simple moving average is $558.29 and its 200-day simple moving average is $532.25. The firm has a market cap of $180.90 billion, a price-to-earnings ratio of 79.24, a PEG ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Robert W. Baird reduced their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.